ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,197.33
      0.32%
      US Tech 100
      17,667.98
      0.33%
      Dow Jones
      38,918.13
      0.17%
      Brent Oil
      83.435
      -0.05%
      Bitcoin
      63,885.58
      1.14%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      Unknown symbol
      		Date:
      Sort by:
      DateTimeSourceHeadlineSymbolCompany
      12:51PMiHub NewswireFeaturedCannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa
      05/07/202412:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MINMMinim Inc
      05/07/202412:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UVSPUnivest Financial Corporation
      05/07/202412:09PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VALNValneva SE
      05/07/202412:09PMBusiness WirePernod Ricard : déclaration des droits de vote - avril 2024
      05/07/202412:09PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:MSTLWMorgan Stanley (PK)
      05/07/202412:08PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARCBArcBest Corporation
      05/07/202412:08PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:UNOVInnovator US Equity Ultra Buffer ETF November
      05/07/202412:08PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:WUCTETRACS Whitney US Critical Technologies Index ETN
      05/07/202412:07PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:NBLWFNoble Corporation PLC (PK)
      05/07/202412:07PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:BLKBlackRock Inc
      05/07/202412:07PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:VXZiPath Series B S&P 500 VIX MidTerm Futures ETN
      05/07/202412:07PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:AORTArtivion Inc
      05/07/202412:07PMPR Newswire (Canada)Grève prochaine chez Autobus Camille Mailloux
      05/07/202412:07PMPR Newswire (Canada)Musée national de l'histoire du Québec - Personne n'effacera les Premières Nations de l'histoire du Québec
      05/07/202412:06PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:GSCEGoldman Sachs Group Inc (PK)
      05/07/202412:06PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SYBTStock Yards Bancorp Inc
      05/07/202412:06PMBusiness WireAcclaim Lighting Introduces Adapt Linear DMX™ LED Fixtures for Increased Flexibility and Easy Installation
      05/07/202412:06PMPR Newswire (Canada)PROPOSED $8 MILLION SETTLEMENT REACHED IN CLOUGHLEY SEX ABUSE CLASS ACTION LAWSUIT AGAINST THE TERRITORY OF NUNAVUT ON BEHALF OF STUDENTS IN SCHOOLS LOCATED IN RESOLUTE BAY OR CLYDE RIVER
      05/07/202412:06PMPR Newswire (Canada)PROPOSITION DE RÈGLEMENT DE 8 MILLIONS DE DOLLARS CONCLU DANS LE CADRE DU RECOURS COLLECTIF SUR LES ABUS SEXUELS DE CLOUGHLEY INTENTÉ CONTRE LE TERRITOIRE DU NUNAVUT AU NOM DES ÉLÈVES DES ÉCOLES SITUÉES À RESOLUTE BAY OU À CLYDE RIVER
      05/07/202412:05PMGlobeNewswire Inc.AB Science : A new publication in the medical journal Muscle & Nerve validates the use of the rate of decline of ALSFR-S score (ΔFS) for the design of clinical studies and the treatment choice for amyotrophic lateral sclerosis (ALS) patientEU:ABAb Science
      05/07/202412:05PMGlobeNewswire Inc.AB Science:LSE:0Q77Ab Science Sa
      05/07/202412:05PMGlobeNewswire Inc.AB Science:EU:ABAb Science
      05/07/202412:05PMGlobeNewswire Inc.AB Science : A new publication in the medical journal Muscle & Nerve validates the use of the rate of decline of ALSFR-S score (ΔFS) for the design of clinical studies and the treatment choice for amyotrophic lateral sclerosis (ALS) patientLSE:0Q77Ab Science Sa
      05/07/202412:05PMGlobeNewswire Inc.AB Science:TG:A8DAb Science
      05/07/202412:05PMGlobeNewswire Inc.AB Science : A new publication in the medical journal Muscle & Nerve validates the use of the rate of decline of ALSFR-S score (ΔFS) for the design of clinical studies and the treatment choice for amyotrophic lateral sclerosis (ALS) patientTG:A8DAb Science
      05/07/202412:05PMGlobeNewswire Inc.AB Science : A new publication in the medical journal Muscle & Nerve validates the use of the rate of decline of ALSFR-S score (ΔFS) for the design of clinical studies and the treatment choice for amyotrophic lateral sclerosis (ALS) patientEU:ABAb Science
      05/07/202412:05PMPR Newswire (Canada)/C O R R E C T I O N from Source -- LGI Healthcare Solutions/
      05/07/202412:05PMPR Newswire (US)/C O R R E C T I O N from Source -- LGI Healthcare Solutions/
      05/07/202412:04PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:VXZiPath Series B S&P 500 VIX MidTerm Futures ETN